1. AMJC. FDA Approves ofatumumab for relapsing MS. 2020. Available at: https://www.ajmc.com/view/fda-approves-ofatumumab-for-relapsing-ms. Accessed March 2023.
2. Aubagio®. Prescribing information. 2022. Available at: https://products.sanofi.us/aubagio/aubagio.pdf. Accessed March 2023.
3. Aubagio®. Summary of product characteristics. 2022. Available at: https://www.medicines.org.uk/emc/product/5244. Accessed March 2023.
4. Avonex®. Summary of product characteristics. 2023. Available at: https://www.medicines.org.uk/emc/product/886/smpc/. Accessed March 2023.
5. Avonex®. Prescribing information. 2021. Available at: https://www.avonex.com/content/dam/commercial/avonex/pat/en_us/pdf/Avonex_US_Prescribing_Information.pdf. Accessed March 2023.